Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: A case report

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Baldini, Chiara ^a   Giusti, Laura ^a   Ciregia, Federica ^a   Da Valle, Ylenia ^a   Giacomelli, Camillo ^a   Donadio, Elena ^a   Ferro, Francesco ^a   Galimberti, Sara ^a   Donati, Valentina ^b   Bazzichi, Laura ^a   Bombardieri, Stefano ^a   Lucacchini, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Azienda Ospedaliero Universitaria Pisana   (Italy)

Author keywords

B cell non Hodgkin's lymphoma; Primary Sj gren's Syndrome; Proteomic analysis

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; CYCLOPHOSPHAMIDE; HAPTOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN J; IMMUNOGLOBULIN KAPPA CHAIN; RITUXIMAB; UNCLASSIFIED DRUG; PROTEOME; SALIVA PROTEIN;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; DISEASE COURSE; DRUG INFUSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NUCLEOTIDE SEQUENCE; PAROTID GLAND CANCER; PROTEIN EXPRESSION; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; SALIVARY GLAND CANCER; SJOEGREN SYNDROME; TREATMENT RESPONSE; TWO DIMENSIONAL ELECTROPHORESIS; CHEMISTRY; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; NONHODGKIN LYMPHOMA; PAROTID GLAND; PATHOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PAROTID GLAND; PROTEOME; SALIVARY PROTEINS AND PEPTIDES; SJOGREN'S SYNDROME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 80055108879     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-188     Document Type: Article

References (25)

1. Mariette X, Gottenberg JE. Pathogenesis of Sjögren's syndrome and therapeutic consequences. Curr Opin Rheumatol 2010, 22:471-477. 10.1097/BOR.0b013e32833c36c5, 20671520.
2. Baturone R, Soto MJ, Márquez M, Macías I, de Oca MM, Medina F, Chozas N, García-Pérez S, Girón-González JA. Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines. Scand J Rheumatol 2009, 38:386-389. 10.1080/03009740902973821, 19575332.
3. Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Mortality in Sjögren's syndrome. Clin Exp Rheumatol 2008, 26:S66-71.
4. Voulgarelis M, Moutsopoulos HM. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis. Rheum Dis Clin North Am 2008, 34:921-933. 10.1016/j.rdc.2008.08.006, 18984412.
5. Giusti L, Baldini C, Bazzichi L, Ciregia F, Tonazzini I, Mascia G, Giannaccini G, Bombardieri S, Lucacchini A. Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome. Proteomics 2007, 7:1634-1643. 10.1002/pmic.200600783, 17436266.
6. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, Zhou H, Henry S, Vissink A, Pijpe J, Kallenberg C, Elashoff D, Loo JA, Wong DT. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum 2007, 56:3588-3600. 10.1002/art.22954, 2856841, 17968930.
7. Hu S, Zhou M, Jiang J, Wang J, Elashoff D, Gorr S, Michie SA, Spijkervet FK, Bootsma H, Kallenberg CG, Vissink A, Horvath S, Wong DT. Systems biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotidglands. Arthritis Rheum 2009, 60:81-92. 10.1002/art.24150, 2718690, 19116902.
8. Peluso G, De Santis M, Inzitari R, Fanali C, Cabras T, Messana I, Castagnola M, Ferraccioli GF. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum 2007, 56:2216-22. 10.1002/art.22738, 17599740.
9. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, . European Study Group on Classification Criteria for Sjögren's Syndrome Classification criteria for Sjögren's syndrome: a revised version of the European criteriaproposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-8. 10.1136/ard.61.6.554, 1754137, 12006334, European Study Group on Classification Criteria for Sjögren's Syndrome.
10. Hochstrasser DF, Patchornik A, Merril CR. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Annal Biochem 1988, 173:412-423.
11. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392. 10.1021/ac025747h, 12403597.
12. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658. 10.1021/ac0341261, 14632076.
13. Giusti L, Baldini C, Bazzichi L, Bombardieri S, Lucacchini A. Proteomic diagnosis of Sjögren's syndrome. Expert Rev Proteomics 2007, 4:757-767. 10.1586/14789450.4.6.757, 18067414.
14. Ryu OH, Atkinson JC, Hoehn GT, Illei GG, Hart TC. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 2006, 45:1077-86. (Oxford), 10.1093/rheumatology/kei212, 16522680.
15. Hu S, Gao K, Pollard R, Arellano-Garcia M, Zhou H, Zhang L, Elashoff D, Kallenberg CG, Vissink A, Wong DT. Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res 2010, 62:1633-8. (Hoboken).
16. Hansen A, Reiter K, Pruss A, Loddenkemper C, Kaufmann O, Jacobi AM, Scholze J, Lipsky PE, Dörner T. Dissemination of a Sjögren's syndrome-associated extranodal marginal-zone B cell lymphoma: circulating lymphoma cells and invariant mutation pattern of nodal Ig heavy- and light-chain variable-region gene rearrangements. Arthritis Rheum 2006, 54:127-137. 10.1002/art.21558, 16385504.
17. Lee CC, Ho HC, Lee MS, Hung SK, Yu CC, Su YC. Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma. Clin Chim Acta 2010, 411:1116-1121. 10.1016/j.cca.2010.04.010, 20417195.
18. Lai CH, Chang NW, Lin CF, Lin CD, Lin YJ, Wan L, Sheu JJ, Chen SY, Huang YP, Sing YT, Tao TW, Lai CK, Tsai MH, Chan HL, Jou YJ, Lin CW. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma. Clin Chim Acta 2010, 411:984-991. 10.1016/j.cca.2010.03.028, 20359475.
19. Yang Y, Zhao S, Fan Y, Zhao F, Liu Q, Hu W, Liu D, Fan K, Wang J, Wang J. Detection and identification of potential biomarkers of non-small cell lung cancer. Technol Cancer Res Treat 2009, 8:455-466.
20. Nabli H, Tuller E, Sharpe-Timms KL. Haptoglobin expression in endometrioid adenocarcinoma of the uterus. Reprod Sci 2010, 17:47-55. 10.1177/1933719109346331, 19801537.
21. Fan Y, Shi L, Liu Q, Dong R, Zhang Q, Yang S, Fan Y, Yang H, Wu P, Yu J, Zheng S, Yang F, Wang J. Discovery and identification of potential biomarkers of papillary thyroid carcinoma. Mol Cancer 2009, 8:79. 10.1186/1476-4598-8-79, 2761863, 19785722.
22. Hamrita B, Chahed K, Trimeche M, Guillier CL, Hammann P, Chaïeb A, Korbi S, Chouchane L. Proteomics-based identification of α1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. Clin Chim Acta 2009, 404:111-118. 10.1016/j.cca.2009.03.033, 19306859.
23. Epelbaum R, Shalitin C, Segal R, Valansi C, Arselan I, Faraggi D, Leviov M, Ben Shahar M, Haim N. Haptoglobin-related protein as a serum marker in malignant lymphoma. Pathol Oncol Res 1998, 4:271-276. 10.1007/BF02905217, 9887357.
24. Oikonomopoulou K, Diamandis EP, Hollenberg MD. Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier. Biol Chem 2010, 391:299-310. 10.1515/BC.2010.038, 20180639.
25. Gast MC, van Dulken EJ, van Loenen TK, Kingma-Vegter F, Westerga J, Flohil CC, Knol JC, Jimenez CR, van Gils CH, Wessels LF, Schellens JH, Beijnen JH. Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling. Int J Biol Markers 2009, 24:130-141.